can you ever stop taking a glp 1 What Happens When Patients GLP-1 Medications? Why Do a Significant Number

New consensus from multiple societies on GLP1 and dual GLP1/GIP RAs as adjuncts in #T1D: recognize offlabel use, outline potential benefits (glycemia, weight, insulin dose) but stress careful insulin titration, CGM and ketone monitoring, and structured education for safe implementation

, GSH :

HISTORICAL PERSPECTIVE LEADING TO THE GUIDANCE FOR INDUSTRY The University Group Diabetes Program (UGDP) 17 was among the first to shed light on CV implications of therapies used to treat T2DM ( Figure 2 )

Events involving suspected renal, hematologic, neurologic, dermatologic and hepatic effects have also been reported

From a research standpoint, the two peptides serve different purposes and contribute to different scientific questions